About the Company
talaris therapeutics is a late-clinical stage biotechnology company based in boston, ma and louisville, ky. talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. the company was founded on technology discovered and developed by dr. suzanne ildstad and operates its own cell processing facility in louisville. talaris is backed by leading life sciences investors blackstone life sciences, longitude capital and qiming venture partners usa.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
125
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TALS News
Pearl River-based Acorda Therapeutics to close; 97 jobs impacted
P EARL RIVER - Acorda Therapeutics, which manufactures key medications used by MS and Parkinson's patients, will lay off all ...
We don't have any news on Talaris Therapeutics Inc at the moment.
Loading the latest forecasts...